Serenus.AI specializes in the development of advanced Generative AI technologies that empower medical decisions at critical medical crossroads on patient pathways, saving lives and valuable resources. Our flagship product is the first (registered patent and 4 patents pending) clinically objective, Generative AI, automated case-by-case system to improve decision-making before medical procedures and treatments, while prioritizing patients' waiting lists. Serenus.AI advanced the quality and equality of healthcare delivery, saves valuable resources, and boosts patients', physicians', and payers' satisfaction across the board.
The system's algorithms replicate the objective decision-making processes of top physicians by combining up-to-date medical practices, professional knowledge, and machine-learning technologies.
The Serenus.AI solution is compatible with every type of health system, including US insurance companies and public health systems. The solution has been validated in practice, and the company is currently active in Europe and the United States with stakeholders in the healthcare field.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Serenus.AI Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
May 18, 2021
www.prnewswire.com
Serenus.AI Granted New US Patent for 'AUTOMATED METHOD AND SYSTEM FOR SCREENING AND PREVENTION OF UNNECESSARY MEDICAL PROCEDURES'
#Customers #Partners
Feb 3, 2021
www.haaretz.com
Serenus.AI - Innovative AI-based technology for improved medical treatment decisions
#Customers #Partners
Sep 14, 2020
www.prweb.com
Serenus.AI and HealthTrio team up to innovate the authorization process through the use of advanced machine learning
#Partners
Jul 13, 2020
www.birdf.com
BIRD to invest $8 Million in 10 New Projects - BIRD Foundation